Full Text View
Tabular View
No Study Results Posted
Related Studies
Randomized Trial of Hydrocortisone in Very Preterm High-Risk Infants
This study has been completed.
Study NCT00167544   Information provided by Nationwide Children's Hospital

First Received on September 9, 2005.   Last Updated on December 5, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Bronchopulmonary Dysplasia
Encephalomalacia
Premature Birth
More general conditions related to this trial
Brain Diseases
Central Nervous System Diseases
Infant, Newborn, Diseases
Infant, Premature, Diseases
Lung Diseases
Lung Injury
Nervous System Diseases
Obstetric Labor Complications
Obstetric Labor, Premature
Pregnancy Complications
Respiratory Tract Diseases
Ventilator-Induced Lung Injury
Interventions listed in this trial
Hydrocortisone
Placebo
Additional drug interventions recognized in this trial
Anti-Inflammatory Agents
Cortisol succinate
Hydrocortisone 17-butyrate 21-propionate
Hydrocortisone acetate
Hydrocortisone-17-butyrate
More general drug interventions related to this trial
Dermatologic Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Nationwide Children's Hospital
National Institutes of Health (NIH)
National Institute of Neurological Disorders and Stroke (NINDS)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services